FDA.reportPublic FDA data

somatrogon-ghla 60 MG in 1.2 ML Pen Injector

RxCUI
2644526
RxNorm name
somatrogon-ghla 60 MG in 1.2 ML Pen Injector
Display name
somatrogon-ghla 60 MG in 1.2 ML Pen Injector
Full name
somatrogon-ghla 60 MG in 1.2 ML Pen Injector
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761184Ngenlasomatrogon-ghla351(a)Rx2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NgenlaSOMATROGON-GHLAPfizer Laboratories Div Pfizer Inc06dce529-b741-4a1b-8842-3ad77be6e3082026-08-14Warnings, Adverse reactionsExact identifier
rxcui: 2644526

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
06dce529-b741-4a1b-8842-3ad77be6e308somatrogon-ghla 60 MG in 1.2 ML Pen Injector [PSN] · 1.2 ML somatrogon-ghla 50 MG/ML Pen Injector [SCD] · somatrogon-ghla 50 MG/ML per 1.2 ML Pen Injector [SY] · somatrogon-ghla 60 MG per 1.2 ML Pen Injector [SY]412These highlights do not include all the information needed to use NGENLA safely and effectively. See full prescribing information for NGENLA. NGENLA (somatrogon-ghla) injection, for subcutaneous use Initial U.S. Approval: 202320260507